rs145258166

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001365536.1(SCN9A):​c.3329C>T​(p.Ser1110Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,598,036 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1110P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00062 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000092 ( 1 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

7
7
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 9.56

Publications

4 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028585255).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.3329C>T p.Ser1110Leu missense_variant Exon 17 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.3329C>T p.Ser1110Leu missense_variant Exon 17 of 27 NM_001365536.1 ENSP00000495601.1
SCN9AENST00000303354.11 linkc.3329C>T p.Ser1110Leu missense_variant Exon 17 of 27 5 ENSP00000304748.7
SCN9AENST00000409672.5 linkc.3296C>T p.Ser1099Leu missense_variant Exon 17 of 27 5 ENSP00000386306.1
SCN9AENST00000645907.1 linkc.3296C>T p.Ser1099Leu missense_variant Exon 17 of 27 ENSP00000495983.1

Frequencies

GnomAD3 genomes
AF:
0.000612
AC:
93
AN:
151960
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00215
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000194
AC:
46
AN:
236918
AF XY:
0.000187
show subpopulations
Gnomad AFR exome
AF:
0.00249
Gnomad AMR exome
AF:
0.000120
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000280
Gnomad OTH exome
AF:
0.000520
GnomAD4 exome
AF:
0.0000920
AC:
133
AN:
1445958
Hom.:
1
Cov.:
31
AF XY:
0.0000934
AC XY:
67
AN XY:
717158
show subpopulations
African (AFR)
AF:
0.00229
AC:
76
AN:
33194
American (AMR)
AF:
0.000183
AC:
8
AN:
43620
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25512
East Asian (EAS)
AF:
0.0000509
AC:
2
AN:
39274
South Asian (SAS)
AF:
0.0000593
AC:
5
AN:
84330
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52860
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
0.0000300
AC:
33
AN:
1101680
Other (OTH)
AF:
0.000151
AC:
9
AN:
59780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000618
AC:
94
AN:
152078
Hom.:
0
Cov.:
31
AF XY:
0.000619
AC XY:
46
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.00217
AC:
90
AN:
41502
American (AMR)
AF:
0.000197
AC:
3
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68000
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
0
Bravo
AF:
0.000771
ESP6500AA
AF:
0.00243
AC:
9
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000240
AC:
29

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4
Dec 27, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2022
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 04, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Inborn genetic diseases Uncertain:1
Sep 14, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.S1099L variant (also known as c.3296C>T), located in coding exon 16 of the SCN9A gene, results from a C to T substitution at nucleotide position 3296. The serine at codon 1099 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.0090
T
BayesDel_noAF
Pathogenic
0.21
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.54
.;D;.;.;D;.
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;.;D;D;D;D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.029
T;T;T;T;T;T
MetaSVM
Uncertain
0.35
D
MutationAssessor
Pathogenic
3.1
.;M;.;.;M;M
PhyloP100
9.6
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-4.6
D;.;.;.;.;D
REVEL
Uncertain
0.61
Sift
Pathogenic
0.0
D;.;.;.;.;D
Sift4G
Benign
0.11
T;T;.;.;.;T
Vest4
0.56
MVP
0.89
MPC
0.46
ClinPred
0.21
T
GERP RS
5.4
Varity_R
0.70
gMVP
0.33
Mutation Taster
=17/83
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145258166; hg19: chr2-167128931; COSMIC: COSV57609662; COSMIC: COSV57609662; API